Supernus: New Approval Holds Promise Of Increased Growth
Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...
Gain Therapeutics, Inc.: Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...
Supernus Pharmaceuticals, Inc.: Supernus Announces FDA Approval of ONAPGO (apomorphine hydrochloride) for Parkinson's Disease
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...
Hosted on MSN6d
Lancashire hotel 'must close to asylum seekers,' says MP
Blackpool South MP Chris Webb has renewed calls for the Metropole Hotel to be closed to asylum seekers – claiming its residents have suffered ill-treatment. Mr Webb wants the hotel on Central ...